Zydus Cadila submits additional data to DCGI: Sources

Jul 27, 2021

New Delhi [India], July 27 : Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety to India's drug regulator Drugs Controller...

Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI

Mar 18, 2022

New Delhi [India], March 18 : Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to...

Emergency approval for Zydus Cadila to take few more days, say sources

Jul 12, 2021

New Delhi [India], July 12 : India's drug regulator Drugs Controller General of India (DCGI) will consider giving emergency use authorisation (EUA) to Zydus...

Zydus Cadila submits additional data to DCGI for its COVID-19 vaccine: Sources

Jul 27, 2021

New Delhi [India], July 27 : Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety, on its three-dose COVID-19 vaccine ZyCoV-D,...

DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3 clinical trials in India

Aug 02, 2020

New Delhi, [India], Aug 3 India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India...

Drugs Controller General of India bans all charges, except supply, processing costs on blood units

Jan 04, 2024

The Drugs Controller General of India (DCGI) has waived all charges except processing costs on blood units.